Sectors
IRD
Opus Genetics, Inc.
3.02
9 x 3.01
9 x 3.03
bid
ask
-
0.04
1.14%
01:54 PM
timesize
| Ytd | 50.50% | |
| 1y | 147.95% |
3.00
day range
3.10
1.06
52 week range
5.75
| Open | 3.03 | Prev Close | 3.06 | Low | 3.00 | High | 3.10 | Mkt Cap | 252.65M |
| Vol | 241.01K | Avg Vol | 1.01M | EPS | -1.18 | P/E | -2.59 | Forward P/E | -1.20 |
| Beta | 0.55 | Short Ratio | 4.69 | Inst. Own | 8.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 4.11 | 200-d Avg | 3.40 | 1yr Est | 10.50 |
| Income Statement | |||
| Total Revenue | 2.16M | ||
| Revenues (USD) | 2.16M | ||
| Gross Profit | 2.16M | ||
| Operating Expenses | 16.52M | ||
| Research and Development Expense | 10.58M | ||
| Selling, General and Administrative Expense | 5.94M | ||
| Operating Income | -14.36M | ||
| Interest Expense | 69.00K | ||
| Net Income | -65.53M | ||
| Net Income Common Stock | -65.53M | ||
| Net Income Common Stock (USD) | -65.53M | ||
| Consolidated Income | -65.53M | ||
| Earnings per Basic Share | -0.75 | ||
| Earnings per Basic Share (USD) | -0.75 | ||
| Earnings per Diluted Share | -0.75 | ||
| Earning Before Interest & Taxes (EBIT) | -65.47M | ||
| Earning Before Interest & Taxes (USD) | -65.47M | ||
| Weighted Average Shares | 86.89M | ||
| Weighted Average Shares Diluted | 86.89M | ||
| Balance Sheet | |||
| Cash and Equivalents | 59.96M | ||
| Cash and Equivalents (USD) | 59.96M | ||
| Trade and Non-Trade Receivables | 2.72M | ||
| Current Assets | 66.60M | ||
| Property, Plant & Equipment Net | 186.00K | ||
| Total Assets | 66.79M | ||
| Current Liabilities | 9.34M | ||
| Total Liabilities | 87.89M | ||
| Accumulated Retained Earnings (Deficit) | -254.12M | ||
| Shareholders Equity | -45.84M | ||
| Shareholders Equity (USD) | -45.84M | ||
| Assets Non-Current | 186.00K | ||
| Liabilities Non-Current | 78.55M | ||
| Trade and Non-Trade Payables | 4.42M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 13.00K | ||
| Net Cash Flow from Financing | 27.60M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 14.87M | ||
| Issuance (Purchase) of Equity Shares | 2.96M | ||
| Net Cash Flow from Operations | -12.73M | ||
| Share Based Compensation | 1.46M | ||